Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744904 | Clinical Microbiology and Infection | 2018 | 28 Pages |
Abstract
Among hospitalized patients with HIV/AIDS with CAP, treatment with ceftriaxone and a macrolide did not improve patient outcomes, when compared with ceftriaxone monotherapy.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
C. Figueiredo-Mello, P. Naucler, M.D. Negra, A.S. Levin,